2nd Quarter - Report

JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC

Firm
Client
Income
—
Expenses
$1,760,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

11 issue areas, each in the filer's own words, with who lobbied on it and where.

Veterans VET

- Issues related to VA medical device procurement issues

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
LEIF BRIERLEY —
ANNE BRUCE —
RILEY SWINEHART —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Trade (domestic/foreign) TRD

-Issues related to new tariff proclamations and retaliation. - Issues related to mandatory supply chain requirements, including under Buy America. - H.R.6930, "MADE in America Act of 2020", regarding all provisions

LobbyistCovered position, as disclosed
MICHAEL BARNARD —
LEIF BRIERLEY —
DAVID KAVANAUGH —
RILEY SWINEHART —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office

Bills named: H.R. 6930 (116th)

Taxation/Internal Revenue Code TAX

- Issues related to spending and linked to corporate tax rate - H.R.1711/S.780 - No Tax Breaks for Outsourcing Act, regarding all provisions - H.R.1712/S.779 - Stop Tax Haven Abuse Act, regarding all provisions - Issues related to CFC look through. - Issues related to the implementation of the Tax Cut and Jobs Act of 2017 - H.R. 1922/S. 1089 -"Restoring Access to Medication Act of 2019", regarding all provisions. - H.R. 748/ S. 3458, "Coronavirus Aid, Relief, and. Economic Security Act", regarding tax provisions and future stimulus bills. - Issues related to supply chain investment incentives.

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
DARREL C JODREY —
DAVID KAVANAUGH —
RILEY SWINEHART —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Bills named: H.R. 1922 (116th), S. 780 (116th), S. 1089 (116th), H.R. 1712 (116th), S. 779 (116th), H.R. 1711 (116th), S. 3458 (116th), H.R. 748 (116th)

Environment/Superfund ENV

- H.R. 1834 - Defending our National Marine Sanctuaries from Damaging Chemicals Act of 2019, regarding all provisions - H.R. 2588/S. 1371 - Oxybenzone and Octinoxate Impact Study Act of 2019, regarding all provisions - H.R. 2587/S. 1375 - Reef Safe Act of 2019, regarding all provisions - Issues related to sterilization of medical devices - Issues regarding environmental sustainability

LobbyistCovered position, as disclosed
DARREL C JODREY —
MEGHAN DRENAN STONE —
RILEY SWINEHART —
KELLY WATERS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; White House Office

Bills named: S. 1371 (116th), H.R. 2587 (116th), H.R. 2588 (116th), H.R. 1834 (116th), S. 1375 (116th)

Labor Issues/Antitrust/Workplace LBR

- Issues related to corporate governance - Issues related to diversity & inclusion - Issues related to racial equity and justice - Issues related to livability reform protections

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
LARRY CAMM New —
RILEY SWINEHART —
KELLY WATERS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office

Torts TOR

- Issues related to civil justice reform.

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
LARRY CAMM —
RILEY SWINEHART —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; White House Office

Science/Technology SCI

- Issues related to data privacy. - Issues related to artificial intelligence.

LobbyistCovered position, as disclosed
LEIF BRIERLEY —
RILEY SWINEHART —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Copyright/Patent/Trademark CPT

- Patent Trade Office reforms - H.R.1520, "Purple Book Continuity Act of 2019", regarding all provisions - H.R.1503, "Orange Book Transparency Act of 2019", regarding all provisions - H.R.1499 "Protecting Consumer Access to Generic Drugs Act of 2019", regarding all provisions - S.659, "Biologic Patent Transparency Act", regarding all provisions. - S. 1419, "Early Participation in Regulations Act of 2019", regarding all provisions

LobbyistCovered position, as disclosed
MICHAEL BARNARD —
ANNE BRUCE —
DAVID KAVANAUGH —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1499 (116th), S. 1419 (116th), S. 659 (116th), H.R. 1503 (116th), H.R. 1520 (116th)

Health Issues HCR

- H.R. 863 - DXM Abuse Prevention Act of 2019, regarding all provisions - S. 726 - Personal Care Products Safety Act, regarding all provisions - Issues related to the regulation of over-the-counter drugs - Issues related to cosmetic regulatory reform - Issues related to cosmetic animal testing - Issues related to biosimilars - Issues related to maternal mortality - Issues related to contact lens safety - Issues related to medical product communications - Issues related to medical product review - Issues related to ingredient safety - Issues related to diversity in clinical trials - Issues related to health care pricing transparency - Issues related to peripheral artery disease - H.R. 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - Issues related to drug importation - S. 2543, "Prescription Drug Pricing Reduction Act of 2019", regarding all provisions - H.R. 19, "Lower Costs, More Cures Act of 2019", regarding all provisions - H.R. 748/ S. 3458, "'Coronavirus Aid, Relief, and. Economic Security Act'', regarding all provisions - H.R. 6074, "Coronavirus Preparedness and Response Supplemental Appropriations Act", regarding all provisions - H.R. 6201, "Families First Coronavirus Response Act", regarding all provisions - H.R. 3975, the Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 5663, the Safeguarding Therapeutics Act, regarding all provisions - Issues related to counterfeit health care goods - S. 3468, Preventing Essential Medical Device Shortages Act of 2020 - Issues related to counterfeit medical devices and combination products and authority to destroy counterfeit medical products - Issues related to reporting medical device shortages - Issues related to pandemic response - S. 2740, "Over the Counter Monograph Safety, Innovation, and Reform Act of 2019", regarding all provisions - H.R. 5279, "Cosmetic Safety Enhancement Act", regarding all provisions - H.R. 4296, "Safe Cosmetics and Personal Care Products Act of 2019", regarding all provisions - Issues related to social determinants of health - H.R. 5076/S. 1872, "Protecting Seniors Through Immunization", regarding all provisions - H.R.6062, "To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes", regarding all provisions. - H.R.6952, "To direct the President to appoint a Medical Supplies Response Coordinator to coordinate the efforts of the Federal Government regarding the supply and distribution of certain supplies and equipment relating to COVID-19", regarding all provisions - S.3942, "Securing America's Medical Supply Chain and Advancing the Production of Life Saving Medicines Act", regarding all provisions - S.3945, "Bring Entrepreneurial Advancements To Consumers Here In North America Act", regarding all provisions - S.3780, "HOME Act", regarding all provisions - S.3781, "PART Act", regarding all provisions - Issues related to diversity in clinical trials

Contacted: SENATE; White House Office; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3 (116th), H.R. 4296 (116th), H.R. 19 (116th), H.R. 5279 (116th), S. 3945 (116th), H.R. 5663 (116th), S. 2543 (116th), S. 3780 (116th), H.R. 5076 (116th), S. 3942 (116th), S. 3458 (116th), H.R. 6952 (116th), S. 3468 (116th), H.R. 6201 (116th), S. 726 (116th), S. 1872 (116th), S. 3781 (116th), H.R. 863 (116th), H.R. 748 (116th), H.R. 3975 (116th), H.R. 6062 (116th), H.R. 6074 (116th), S. 2740 (116th)

Medicare/Medicaid MMM

- Issues related to reimbursement - HR 1425, "The Patient Protection and Affordable Care Enhancement Act", regarding all provisions - Issues related to antimicrobial resistance - Issues relating to vaccine coverage

LobbyistCovered position, as disclosed
MICHAEL BARNARD —
ANNE BRUCE —
ABIGAIL PINKELE —
RILEY SWINEHART —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1425 (116th)

Budget/Appropriations BUD

-Issues related to FY2020 Appropriations, specifically The Global Fund, Food & Drug Administration, Commerce, Interior, National Institutes of Health and Environmental Protection Agency budgets. -Issues related to frontline health workers -Issues related to maternal mortality and morbidity -H.R. 6800, "Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act", regarding all provisions

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
LEIF BRIERLEY —
LARRY CAMM —
DARREL C JODREY —
MEGHAN DRENAN STONE —
RILEY SWINEHART —
KELLY WATERS —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6800 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.